These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 1301361)
21. Simultaneous quantitation of d7-nefazodone, nefazodone, d7-hydroxynefazodone, hydroxynefazodone, m-chlorophenylpiperazine and triazole-dione in human plasma by liquid chromatographic-mass spectrometry. Yao M; Srinivas NR Biomed Chromatogr; 2000 Apr; 14(2):106-12. PubMed ID: 10694704 [TBL] [Abstract][Full Text] [Related]
23. Investigation of pharmacokinetic and pharmacodynamic interactions after coadministration of nefazodone and haloperidol. Barbhaiya RH; Shukla UA; Greene DS; Breul HP; Midha KK J Clin Psychopharmacol; 1996 Feb; 16(1):26-34. PubMed ID: 8834415 [TBL] [Abstract][Full Text] [Related]
24. Characterization of the metabolites of the antidepressant drug nefazodone in human urine and plasma. Mayol RF; Cole CA; Luke GM; Colson KL; Kerns EH Drug Metab Dispos; 1994; 22(2):304-11. PubMed ID: 8013286 [TBL] [Abstract][Full Text] [Related]
26. Assessment of pharmacokinetic and pharmacodynamic drug interactions between nefazodone and digoxin in healthy male volunteers. Dockens RC; Greene DS; Barbhaiya RH J Clin Pharmacol; 1996 Feb; 36(2):160-7. PubMed ID: 8852392 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers. Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580 [TBL] [Abstract][Full Text] [Related]
28. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects. Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971 [TBL] [Abstract][Full Text] [Related]
29. Lack of effect of food on the steady state pharmacokinetics of BMS-181101, an antidepressant, in healthy subjects. Srinivas NR; Shyu WC; Lee J; Greene DS; Barbhaiya RH Biopharm Drug Dispos; 1997 Oct; 18(7):585-93. PubMed ID: 9330779 [TBL] [Abstract][Full Text] [Related]
30. High-performance liquid chromatographic method for the determination of nefazodone and its metabolites in human plasma using laboratory robotics. Franc JE; Duncan GF; Farmen RH; Pittman KA J Chromatogr; 1991 Sep; 570(1):129-38. PubMed ID: 1797818 [TBL] [Abstract][Full Text] [Related]
31. The effect of nefazodone on the single-dose pharmacokinetics of phenytoin in healthy male subjects. Marino MR; Langenbacher KM; Hammett JL; Nichola P; Uderman HD J Clin Psychopharmacol; 1997 Feb; 17(1):27-33. PubMed ID: 9004054 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study. Zhao RK; Cheng G; Tang J; Song J; Peng WX Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103 [TBL] [Abstract][Full Text] [Related]
33. Attenuation of the prolactin-stimulating and hyperthermic effects of nefazodone after subacute treatment. Walsh AE; Cowen PJ J Clin Psychopharmacol; 1994 Aug; 14(4):268-73. PubMed ID: 7962683 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic and pharmacodynamic evaluation of warfarin and nefazodone coadministration in healthy subjects. Salazar DE; Dockens RC; Milbrath RL; Raymond RH; Fulmor IE; Chaikin PC; Uderman HD J Clin Pharmacol; 1995 Jul; 35(7):730-8. PubMed ID: 7560254 [TBL] [Abstract][Full Text] [Related]
35. Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet. Schulz HU; Schürer M; Bässler D; Weiser D Arzneimittelforschung; 2005; 55(1):15-22. PubMed ID: 15727160 [TBL] [Abstract][Full Text] [Related]
36. Effects of age, gender, and diurnal variation on the steady-state pharmacokinetics of BMS-181101, an antidepressant, in healthy subjects. Srinivas NR; Shyu WC; Gleason C; Schuster A; Greene DS; Barbhaiya RH Clin Pharmacol Ther; 1997 Oct; 62(4):408-16. PubMed ID: 9357392 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of 3 times a day dosing of oral treprostinil in healthy volunteers. Jones A; Wang-Smith L; Pham T; Laliberte K J Cardiovasc Pharmacol; 2014 Mar; 63(3):227-32. PubMed ID: 24603117 [TBL] [Abstract][Full Text] [Related]
38. Safety, tolerability and pharmacokinetics of doravirine, a novel HIV non-nucleoside reverse transcriptase inhibitor, after single and multiple doses in healthy subjects. Anderson MS; Gilmartin J; Cilissen C; De Lepeleire I; Van Bortel L; Dockendorf MF; Tetteh E; Ancona JK; Liu R; Guo Y; Wagner JA; Butterton JR Antivir Ther; 2015; 20(4):397-405. PubMed ID: 25470746 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of voriconazole after oral administration of single and multiple doses in Hispaniolan Amazon parrots (Amazona ventralis). Sanchez-Migallon Guzman D; Flammer K; Papich MG; Grooters AM; Shaw S; Applegate J; Tully TN Am J Vet Res; 2010 Apr; 71(4):460-7. PubMed ID: 20367055 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic properties of once-daily oral low-dose mesylate salt of paroxetine (LDMP 7.5 mg) following single and multiple doses in healthy postmenopausal women. Cristina Castelli M; Bhaskar S; Lippman J Clin Ther; 2013 Jun; 35(6):862-9. PubMed ID: 23795577 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]